Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
Clinical trial NCT00346827 · COMPLETED
Trial details
- NCT number
- NCT00346827
- Sponsor
- Britannia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2007-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.